Page last updated: 2024-10-22

amsacrine and Cicatrix

amsacrine has been researched along with Cicatrix in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Cicatrix: The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.

Research Excerpts

ExcerptRelevanceReference
"However, scarring sometimes still occurs."5.51The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery. ( Akaishi, T; Kokubun, T; Nakamura, M; Nakazawa, T; Omodaka, K; Sato, K; Saya, H; Shiga, Y; Shimazaki, A; Tsuda, S; Yamamoto, K, 2019)
"However, scarring sometimes still occurs."1.51The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery. ( Akaishi, T; Kokubun, T; Nakamura, M; Nakazawa, T; Omodaka, K; Sato, K; Saya, H; Shiga, Y; Shimazaki, A; Tsuda, S; Yamamoto, K, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, K1
Kokubun, T1
Sato, K1
Akaishi, T1
Shimazaki, A1
Nakamura, M1
Shiga, Y1
Tsuda, S1
Omodaka, K1
Saya, H1
Nakazawa, T1

Other Studies

1 other study available for amsacrine and Cicatrix

ArticleYear
The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery.
    Scientific reports, 2019, 12-17, Volume: 9, Issue:1

    Topics: Amsacrine; Animals; Callithrix; Cicatrix; Conjunctiva; Disease Models, Animal; DNA Topoisomerases, T

2019